Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care.

@article{Bohan2007AnticonvulsantHS,
  title={Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care.},
  author={KarenBeth H Bohan and Tarannum F Mansuri and Natalie M. Wilson},
  journal={Pharmacotherapy},
  year={2007},
  volume={27 10},
  pages={1425-39}
}
Anticonvulsant hypersensitivity syndrome (AHS) is a delayed adverse drug reaction associated with the use of aromatic anticonvulsant drugs. It has been most commonly reported with the use of phenytoin, carbamazepine, and phenobarbital. Although its occurrence is rare, 1 in every 1000-10,000 exposures, AHS is a serious adverse event often resulting in… CONTINUE READING